IL300133A - Anti-integrin beta7 antibody formulations and devices - Google Patents
Anti-integrin beta7 antibody formulations and devicesInfo
- Publication number
- IL300133A IL300133A IL300133A IL30013323A IL300133A IL 300133 A IL300133 A IL 300133A IL 300133 A IL300133 A IL 300133A IL 30013323 A IL30013323 A IL 30013323A IL 300133 A IL300133 A IL 300133A
- Authority
- IL
- Israel
- Prior art keywords
- devices
- antibody formulations
- integrin beta7
- beta7 antibody
- integrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063059427P | 2020-07-31 | 2020-07-31 | |
| PCT/US2021/043690 WO2022026699A1 (en) | 2020-07-31 | 2021-07-29 | Anti-integrin beta7 antibody formulations and devices |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL300133A true IL300133A (en) | 2023-03-01 |
Family
ID=77693570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL300133A IL300133A (en) | 2020-07-31 | 2021-07-29 | Anti-integrin beta7 antibody formulations and devices |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP4188958A1 (en) |
| JP (1) | JP2023536158A (en) |
| KR (1) | KR20230041071A (en) |
| AR (1) | AR123085A1 (en) |
| AU (1) | AU2021316017A1 (en) |
| BR (1) | BR112023001734A2 (en) |
| CA (1) | CA3190109A1 (en) |
| IL (1) | IL300133A (en) |
| MX (1) | MX2023001157A (en) |
| TW (1) | TW202222832A (en) |
| WO (1) | WO2022026699A1 (en) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| SG48759A1 (en) | 1990-01-12 | 2002-07-23 | Abgenix Inc | Generation of xenogenic antibodies |
| KR100272077B1 (en) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | Transgenic non-human animals capable of producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| EP0861893A3 (en) | 1991-09-19 | 1999-11-10 | Genentech, Inc. | High level expression of immunoglobulin polypeptides |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| KR100654645B1 (en) | 1995-04-27 | 2007-04-04 | 아브게닉스, 인크. | Human Antibodies from Immunized Genomous |
| CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| KR20080059467A (en) | 1996-12-03 | 2008-06-27 | 아브게닉스, 인크. | Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| KR100797667B1 (en) | 1999-10-04 | 2008-01-23 | 메디카고 인코포레이티드 | Method for regulating transcription of foreign genes |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| AU2002213441B2 (en) | 2000-10-12 | 2006-10-26 | Genentech, Inc. | Reduced-viscosity concentrated protein formulations |
| US20050158303A1 (en) | 2003-04-04 | 2005-07-21 | Genentech, Inc. | Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations |
| SI1784426T1 (en) | 2004-09-03 | 2012-03-30 | Genentech Inc | Humanized anti-beta7 antagonists and uses therefor |
| CA2723614C (en) | 2008-05-16 | 2015-07-14 | Genentech, Inc. | Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists |
| RU2011140498A (en) | 2009-03-06 | 2013-04-20 | Дженентек, Инк. | PREPARATION ANTIBODIES |
| PE20141672A1 (en) * | 2011-05-02 | 2014-11-26 | Millennium Pharm Inc | FORMULATION FOR ANTI-alpha4�7 ANTIBODY |
| CA2839496C (en) | 2011-06-17 | 2016-02-09 | Shl Group Ab | Injection device |
| US9022982B2 (en) | 2011-06-17 | 2015-05-05 | Shl Group Ab | Injection device |
| SG11201507974RA (en) | 2013-03-27 | 2015-10-29 | Genentech Inc | Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists |
| CA2939246A1 (en) | 2014-03-27 | 2015-10-01 | Genentech, Inc. | Methods for diagnosing and treating inflammatory bowel disease |
| KR20170120601A (en) * | 2015-02-26 | 2017-10-31 | 제넨테크, 인크. | How to Treat Integrin Beta 7 Antagonists and Crohn's Disease |
| EP3810085A1 (en) * | 2018-06-20 | 2021-04-28 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
-
2021
- 2021-07-29 AU AU2021316017A patent/AU2021316017A1/en active Pending
- 2021-07-29 KR KR1020237006223A patent/KR20230041071A/en unknown
- 2021-07-29 WO PCT/US2021/043690 patent/WO2022026699A1/en active Application Filing
- 2021-07-29 MX MX2023001157A patent/MX2023001157A/en unknown
- 2021-07-29 IL IL300133A patent/IL300133A/en unknown
- 2021-07-29 TW TW110127937A patent/TW202222832A/en unknown
- 2021-07-29 AR ARP210102115A patent/AR123085A1/en unknown
- 2021-07-29 CA CA3190109A patent/CA3190109A1/en active Pending
- 2021-07-29 EP EP21766732.8A patent/EP4188958A1/en not_active Withdrawn
- 2021-07-29 BR BR112023001734A patent/BR112023001734A2/en unknown
- 2021-07-29 JP JP2023506189A patent/JP2023536158A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021316017A1 (en) | 2023-02-16 |
| BR112023001734A2 (en) | 2023-02-28 |
| TW202222832A (en) | 2022-06-16 |
| KR20230041071A (en) | 2023-03-23 |
| AR123085A1 (en) | 2022-10-26 |
| EP4188958A1 (en) | 2023-06-07 |
| CA3190109A1 (en) | 2022-02-03 |
| WO2022026699A1 (en) | 2022-02-03 |
| JP2023536158A (en) | 2023-08-23 |
| MX2023001157A (en) | 2023-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3930676T3 (en) | Polyribonucleotides and cosmetic uses thereof | |
| EP4076448A4 (en) | Fluoroalkyl-oxadiazoles and uses thereof | |
| CA192596S (en) | Cosmetics bottle | |
| IL290141A (en) | Anti-pvrig antibodies formulations and uses thereof | |
| CA196076S (en) | Cosmetic bottle | |
| GB2563725B (en) | Minimizing ringing in wide band gap semiconductor devices | |
| SG11202002414SA (en) | Hair care compositions and methods | |
| IL287003A (en) | Anti-integrin antibodies and uses thereof | |
| IL309884A (en) | Immunoconjugates and methods | |
| SG10202003748WA (en) | Semiconductor devices and methods of operating the same | |
| CA196074S (en) | Cosmetic bottle | |
| IL288944A (en) | Deuterated caffeine and uses thereof | |
| GB201819321D0 (en) | Cavities and active regions | |
| SG11202111188VA (en) | Anti-cd40 antibody and use thereof | |
| IL311070A (en) | Anti-psma antibodies and uses thereof | |
| EP4110066A4 (en) | Formulations and uses thereof | |
| EP4006048A4 (en) | Novel micropeptide hmmw and application thereof | |
| IL300133A (en) | Anti-integrin beta7 antibody formulations and devices | |
| IL289531A (en) | Cd38-binding agents and uses thereof | |
| EP4051319A4 (en) | Anti-cd37 antibody-maytansine conjugates and methods of use thereof | |
| GB2600270B (en) | Polymer-comrprising medical devices and uses thereof | |
| IL288828A (en) | Cd38-binding agents and uses thereof | |
| EP4167970A4 (en) | Non-porcine formulations and methods thereof | |
| EP4112126A4 (en) | Cosmetic | |
| EP3962404A4 (en) | Orthodontic methods and devices |